CN Stock MarketDetailed Quotes

603087 Gan & Lee Pharmaceuticals.

Watchlist
  • 46.38
  • -0.64-1.36%
Market Closed Nov 15 15:00 CST
27.88BMarket Cap48.01P/E (TTM)

Gan & Lee Pharmaceuticals. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gan & Lee Pharmaceuticals. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 710.218M--
--2024/Q4-- / 1.183B--
--2024/Q3930.113M / 1.029B--
Aug 29, 20242024/Q2754.559M / 792.407M--
Apr 25, 20242024/Q1560.334M / 653.729M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 710.218M--
--2024/Q4-- / 1.183B--
--2024/Q3930.113M / 1.029B--
Aug 29, 20242024/Q2754.559M / 792.407M--
Apr 25, 20242024/Q1560.334M / 653.729M--

Unlock Free Earnings Estimates

Gan & Lee Pharmaceuticals. Earnings Reports

  • Third Quarter Report 2024

    Oct 22 12:00 ET

  • 2024 Semi-Annual Report

    Aug 28 12:00 ET

  • 2024 Semi-Annual Report Summary

    Aug 28 12:00 ET

  • Announcement of expected increase in performance for the first half of 2024.

    Jul 8 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 16, 2024

    Strong Buy

    • Strong Buy

      77.78%

    • Buy

      22.22%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data